Journal of Clinical Pediatrics >
Expression and significance of cadherin-11 in liver of children with biliary atresia
Received date: 2021-07-14
Online published: 2022-02-11
Objective To analyze the expression and significance of cadherin-11 (CDH11) in livers of children with biliary atresia (BA). Methods Fifty children with BA and eight children with choledochal cyst (CC) were selected as the research objects. The expression levels of CDH11 and liver fibrotic marker genes in the livers of the children were evaluated by quantitative real-time polymerase chain reaction. The correlation between CDH11 and liver fibrotic marker genes or serum liver function markers was analyzed. Results The mRNA levels of CDH11 were significantly elevated in livers of children with BA compared to children with CC (P< 0.01). Hepatic CDH11 mRNA levels were positively correlated with the expression levels of transforming growth factor beta 1, transforming growth factor beta 2, keratin 19, actin alpha 2, smooth muscle, collagen type I alpha 1 and collagen type IV alpha 1 in children with BA (r= 0.36 ~ 0.73, all P< 0.01). The mRNA levels of CDH11 in livers of BA patients with severe liver fibrosis significantly increased compared to BA patients with mild liver fibrosis (P< 0.01). Hepatic CDH11 mRNA levels were positively correlated with serum levels of γ-glutamyl transferase, total bilirubin, direct bilirubin and bile acid in children with BA (r= 0.26 ~ 0.37, all P< 0.05). Conclusions The mRNA levels of CDH11 were significantly increased in livers of BA patients compared to CC patients. The expression levels of CDH11 were associated with the progression of liver fibrosis and degree of liver injury in BA.
Key words: biliary atresia; cadherin-11; liver fibrosis; liver injury
Bo WU , Xinbei TIAN , Ying LU , Jun DU , Yongtao XIAO . Expression and significance of cadherin-11 in liver of children with biliary atresia[J]. Journal of Clinical Pediatrics, 2022 , 40(2) : 134 -138 . DOI: 10.12372/jcp.2022.21e1058
| [1] | Wang J, Xu Y, Chen Z, et al. Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia[J]. Cell, 2020, 183(7):1867-1883. |
| [2] | Ortiz-Perez A, Donnelly B, Temple H, et al. Innate immunity and pathogenesis of biliary atresia[J]. Front Immunol, 2020, 11:329. |
| [3] | Xiao Y, Liu R, Li X, et al. Long noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia[J]. Hepatology, 2019, 70(5):1658-1673. |
| [4] | Zhou K, Xie G, Wen J, et al. Histamine is correlated with liver fibrosis in biliary atresia[J]. Dig Liver Dis, 2016, 48(8):921-926. |
| [5] | Okubo R, Nio M, Sasaki H, et al. Impacts of early kasai portoenterostomy on short-term and long-term outcomes of biliary atresia[J]. Hepatol Commun, 2021, 5(2):234-243. |
| [6] | Birtolo C, Pham H, Morvaridi S, et al. Cadherin-11 is a cell surface marker up-regulated in activated pancreatic stellate cells and is involved in pancreatic cancer cell migration[J]. Am J Pathol, 2017, 187(1):146-155. |
| [7] | Chen X, Xiang H, Yu S, et al. Research progress in the role and mechanism of Cadherin-11 in different diseases[J]. J Cancer, 2021, 12(4):1190-1199. |
| [8] | Lodyga M, Cambridge E, Karvonen HM, et al. Cadherin-11-mediated adhesion of macrophages to myofibroblasts establishes a profibrotic niche of active TGF-β[J]. Sci Signal, 2019, 12(564):eaao3469. |
| [9] | Franzè E, Monteleone I, Laudisi F, et al. Cadherin-11 Is a Regulator of Intestinal Fibrosis[J]. J Crohns Colitis, 2020, 14(3):406-417. |
| [10] | 杨媛, 孙超, 高伟, 等. 胆道闭锁诊断及治疗指南(2018版)[J]. 临床肝胆病杂志, 2019, 35(11):2435-2440. |
| [11] | 中华医学会外科学分会胆道外科学组. 胆管扩张症诊断与治疗指南(2017版)[J]. 中华消化外科杂志, 2017, (16):767-774. |
| [12] | Ishibashi H, Shimada M, Kamisawa T, et al. Japanese clinical practice guidelines for congenital biliary dilatation[J]. J Hepatobiliary Pancreat Sci, 2017, 24(1):1-16. |
| [13] | Luo Y, Brigham D, Bednarek J, et al. Unique Cho-langiocyte-targeted IgM autoantibodies correlate with poor outcome in biliary atresia[J]. Hepatology, 2021, 73(5):1855-1867. |
| [14] | Schroer AK, Bersi MR, Clark CR, et al. Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction[J]. JCI Insight, 2019, 4(18):e131545. |
| [15] | Kisseleva T, Brenner D. Molecular and cellular mecha-nisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3):151-166. |
| [16] | Dewidar B, Meyer C, Dooley S, et al. TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019[J]. Cells, 2019, 8(11):1419. |
| [17] | Cao W, Song S, Fang G, et al. Cadherin-11 deficiency attenuates ang-II-induced atrial fibrosis and susceptibility to atrial fibrillation[J]. J Inflamm Res, 2021, 14:2897-2911. |
| [18] | Pedroza M, To S, Smith J, et al. Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride[J]. PLoS One, 2019, 14(7):e0218971. |
| [19] | 周艳芬, 邬平, 李欣, 等. 血清GGT、DB在胆道闭锁和胆汁淤积症患儿中的水平变化及意义[J]. 山东医药, 2020, 60(31):15-18. |
/
| 〈 |
|
〉 |